1-1 of 1
Michael S. Buff, MD
Close
Sort by
Journal Articles

90 Y Ibritumomab Tiuxetan and Rituximab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin’s Lymphoma.

Michael S. Buff, MD, Anna Royer, BA, Pamela Ely, MD, PhD, Barbara Grant, MD, J. Anthony Parker, MD, PhD, Robin M. Joyce, MD
Journal: Blood
Blood (2006) 108 (11): 2752.
https://doi.org/10.1182/blood.V108.11.2752.2752
Published: 2006